Lanean...
Novel CD123 polyaptamer hydrogel edited by Cas9/sgRNA for AML-targeted therapy
CD123 targeting molecules have been widely applied in acute myelocytic leukemia (AML) therapeutics. Although antibodies have been more widely used as targeting molecules, aptamer have unique advantages for CD123 targeting therapy. In this study, we constructed an aptamer hydrogel termed as SSFH whic...
Gorde:
| Argitaratua izan da: | Drug Deliv |
|---|---|
| Egile Nagusiak: | , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Taylor & Francis
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8205012/ https://ncbi.nlm.nih.gov/pubmed/34121564 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2021.1934191 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|